Urgent Neurological Evaluation for Acute/Subacute Neuropathy or Spinal Cord Pathology
This 59-year-old man requires immediate neurological assessment with urgent nerve conduction studies, lumbar puncture, and MRI of the spine to differentiate between acute inflammatory neuropathy (such as Guillain-Barré syndrome), chronic inflammatory demyelinating polyneuropathy, or spinal cord compression—all of which can present with unilateral or asymmetric lower extremity weakness, gait instability, and stiffness.
Critical Initial Assessment
The combination of unilateral lower extremity weakness with stiffness creates diagnostic urgency. This presentation does NOT fit typical peripheral artery disease patterns, which present with claudication (pain with walking that resolves with rest) rather than weakness and stiffness 1.
Red Flags Requiring Emergency Evaluation:
- Acute/subacute onset (timeframe unclear but implied by "presents with")
- Motor weakness (not just sensory symptoms)
- Gait instability suggesting either upper motor neuron pathology or severe proprioceptive loss
- Stiffness on palpation which may indicate spasticity (upper motor neuron) or muscle rigidity
Diagnostic Algorithm
Step 1: Immediate Neurological Examination
Perform focused assessment for:
- Deep tendon reflexes: Hyperreflexia suggests upper motor neuron lesion (spinal cord); hyporeflexia/areflexia suggests peripheral neuropathy 2, 3
- Sensory distribution: Dermatomal pattern (radiculopathy/myelopathy) vs. stocking-glove (polyneuropathy) vs. asymmetric (mononeuropathy/plexopathy)
- Upper motor neuron signs: Babinski sign, clonus, spasticity
- Proximal vs. distal weakness pattern: Proximal weakness can occur in GBS variants 2
- Bilateral vs. unilateral involvement: Check contralateral leg carefully
Step 2: Urgent Diagnostic Testing
Within 24-48 hours:
MRI of lumbar and thoracic spine (with and without contrast)
- Rule out spinal cord compression, transverse myelitis, or cauda equina syndrome
- Normal MRI does NOT exclude acute neuropathy 3
Nerve conduction studies and EMG
Lumbar puncture (if no contraindication on MRI)
Step 3: Laboratory Workup
- Complete blood count: Rule out thrombocytosis or systemic disease 4
- Creatine kinase: Elevated suggests muscle damage but can be mildly elevated in neuropathy 2
- Serum protein electrophoresis with immunofixation: Paraproteinemic neuropathies (IgM, IgG) 5
- Antibody panel: Anti-nodal/paranodal antibodies if CIDP suspected 3
- Vitamin B12, TSH, HbA1c: Treatable metabolic causes
Differential Diagnosis Priority
Most Likely (Based on Presentation):
Guillain-Barré Syndrome (GBS) - especially if acute onset over days
- Can present with proximal weakness 2
- Areflexia is hallmark
- Requires IVIG or plasmapheresis urgently
- Risk of respiratory failure
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - if subacute/chronic (>8 weeks)
- Progressive weakness and sensory loss
- Responds to IVIG, steroids, or plasmapheresis
- Must distinguish from nodopathies (different treatment) 3
Spinal cord pathology (myelopathy, compression, transverse myelitis)
- Unilateral presentation more common
- Stiffness suggests spasticity
- Requires urgent neurosurgical evaluation if compressive
Less Likely (But Must Exclude):
Lumbosacral radiculopathy/plexopathy
- Nerve root compression can cause weakness and sensory changes 1
- Usually dermatomal distribution
Paraproteinemic neuropathy - if chronic progressive course
- IgM-associated neuropathy with tremor and ataxia 5
- Requires hematologic workup
Common Pitfalls to Avoid
Do NOT assume peripheral artery disease: PAD presents with claudication (exertional pain), not weakness and stiffness. Pulses should be assessed, but this presentation is neurological 1
Do NOT delay lumbar puncture: Albuminocytological dissociation may not appear until week 2 of GBS, but early LP is still valuable 2
Do NOT miss respiratory compromise: GBS can progress rapidly to respiratory failure. Monitor vital capacity if GBS suspected
Do NOT treat as CIDP without excluding nodopathies: Anti-nodal antibody-associated neuropathies do not respond to standard CIDP treatments and require different immunotherapy 3
Immediate Management Considerations
If GBS is suspected (acute onset, areflexia, ascending weakness):
- Admit for monitoring of respiratory function (vital capacity, negative inspiratory force)
- Initiate IVIG 2 g/kg over 5 days OR plasmapheresis
- Monitor for autonomic instability and SIADH 2
If spinal cord compression suspected (upper motor neuron signs, sensory level):
- Urgent neurosurgical consultation
- High-dose corticosteroids if inflammatory myelitis
If CIDP suspected (subacute/chronic, demyelinating pattern):
- IVIG trial (responds in 2-4 weeks)
- Consider antibody testing before treatment 3
The unilateral presentation with stiffness makes spinal cord pathology a critical consideration that must be excluded first with urgent MRI, while simultaneously pursuing neuropathy workup given the overlapping presentations.